{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-24-007864","form_type":"8-K","ticker":null,"cik":"0000910267","company_name":"TITAN PHARMACEUTICALS INC","filed_at":"2024-11-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.350053+00:00","generated_at":"2026-05-29T17:24:19.828402+00:00","sec_items":["3.01","4.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Titan Pharmaceuticals receives Nasdaq delisting notice for late Q3 filing; auditor Withum resigns","bullets":["Received Nasdaq 5250 Notice on Nov 22 for failure to file Q3 10-Q; compliance plan due Jan 21, 2025, exception to May 19, 2025.","Received Nasdaq 5605 Notice on Nov 25 for audit committee non-compliance due to Brynner Chiam's acting PEO/PFO role; cure until next annual meeting or Nov 6, 2025.","Auditor WithumSmith+Brown resigned effective Nov 22, 2024, citing former CEO's resignation; no disagreements or reportable events.","Company working to file Q3 10-Q and plans to appoint an additional independent director."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-24-007864","json":"https://secwatch.observer/filing/0001829126-24-007864.json","markdown":"https://secwatch.observer/filing/0001829126-24-007864.md","text":"https://secwatch.observer/filing/0001829126-24-007864.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910267/000182912624007864/0001829126-24-007864-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910267/000182912624007864/titanpharma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T17:24:19.828402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aad437454a930e1280c1deb31a11275c0bb7e787","claim":"WithumSmith+Brown, PC resigned as auditor of TITAN PHARMACEUTICALS INC.","evidence_excerpt":"On November 22, 2024, WithumSmith+Brown, PC (\"Withum\") resigned as the Company's independent registered public accounting firm, effective immediately.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/910267/000182912624007864/0001829126-24-007864-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"resignation"},{"label":"Auditor","value":"WithumSmith+Brown, PC"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}